查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855643

输尿管镜设备市场（按设备类型、应用、最终用户、技术和配件划分）—2025-2032年全球预测

Ureteroscopy Devices Market by Device Type, Application, End User, Technology, Accessories - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，输尿管镜设备市场规模将成长 38 亿美元，复合年增长率为 7.32%。

关键市场统计数据
基准年 2024 21.5亿美元
预计年份：2025年 23.1亿美元
预测年份 2032 38亿美元
复合年增长率 (%) 7.32%

全面介绍输尿管镜设备的发展历程，包括临床需求、技术进步、采购动态、对策略性相关人员的影响。

输尿管镜设备处于泌尿系统手术创新和微创医疗服务的交汇点，同时满足了临床医生、医疗系统和患者对更清晰的视野、更低的手术风险和更快的康復的需求。临床上对精准治疗结石和尿路上皮病变的需求，持续推动光学系统、能量传输系统以及辅助耗材的发展，以提升取石和肿瘤切除的流程效率。同时，医院和门诊手术中心不断变化的优先事项正在影响采购週期和设备偏好，而监管和报销环境则决定输尿管镜设备的普及速度。

数位影像处理和一次性平台的技术进步正在推动医疗保健领域资本和营运模式的重新思考。数位软性输尿管镜提高了影像清晰度，并增强了与辅助成像系统的整合度；一次性产品的出现则是为了应对消毒的复杂性、交叉感染的风险以及吞吐量的限制。同时，雷射技术和配件设计（例如旨在提高操作性和碎石效率的取石篮和光纤）的进步，正在缩小临床医生在选择器械时必须权衡的手术方案范围。

在此背景下，相关人员必须权衡临床疗效、手术总成本和供应稳定性。随着诊疗路径日益碎片化，泌尿系统手术在门诊进行的比例不断增加，器械设计和操作环境的完整性将成为商业性成功的关键决定因素。本摘要的其余部分将概述最重要的转变、监管和贸易影响、市场细分影响、区域差异，并为希望有效定位其产品组合的领导者提供明确的建议。

输尿管镜检查领域正在发生变革性变化，影响临床实务、技术应用和商业策略。

输尿管镜器材领域正经历多重整合的变革，这些变革正在改变临床实践和商业性价值。首先，高解析度数位光学技术的成熟正在改变临床医生对影像品质和术中决策的期望，从而能够更精细地表征病变并进行更明确的治疗操作。与手术室视觉化和影像管理系统的日益融合进一步强化了这一转变，提升了输尿管镜在复杂诊断和治疗流程中的作用。

其次，一次性技术的兴起正在重塑采购模式和感染控制策略。医疗机构在评估一次性使用方案时，不仅考虑每次操作的成本，还考虑其效率、再处理工作量以及降低交叉感染风险等因素。这正在形成一种混合采用模式，可重复使用和一次性器械并存，采购决策主要受手术量、消毒能力和临床偏好驱动。

第三，能量传输和配件方面的创新，特别是雷射光纤性能和取石篮设计的进步，正在改变内视镜手术的限制。碎石效率和肿瘤切除精度的提高，减少了分期手术的需求，并扩大了微创治疗的适用人群。这些临床效益正在转化为住院和门诊手术比例的转变。

最后，分散式医疗服务和门诊手术中心的兴起正促使製造商优化产品系列，以提高便携性、简化安装和快速週转率。总而言之，这些转变既为产品开发商及其医疗系统合作伙伴带来了机会，也带来了挑战，需要协调投资于临床培训、实证医学和供应链灵活性，才能实现潜在效益。

2025年美国关税对供应链结构、采购决策与成本透明度的累积影响

近期公布的关税措施和2025年贸易政策讯号凸显了输尿管镜设备产业企业供应链配置的重要性。针对特定医疗设备原料和成品的关税调整迫使製造商和经销商重新评估其采购布局、近岸外包方案和库存策略，以维持成本竞争力和交付可靠性。为此，各企业正日益关註二级和三级供应商的依赖关係，以识别潜在的关税风险，并制定涵盖合约重新谈判、替代采购和选择性垂直整合等应对方案。

这些政策转变也影响定价透明度以及与医疗系统和集团采购组织的合约谈判能力。医疗服务提供者要求更清楚地了解岸成本和紧急条款，采购週期中也越来越多地纳入应对进口关税和供应中断的条款。这些因素累积作用，使得企业更加重视情境规划，并在不同的贸易政策路径下对商业模式进行压力测试。

在製造业方面，一些公司正在加快本地组装或认证非关税区的替代契约製造，以降低关税负担并缩短前置作业时间。另一些公司则在重新设计零件规格，以尽量减少使用关税复杂的物项，还有一些公司则在利用现有的关税减免机制。值得注意的是，这些因应措施并不均衡。中小企业与规模较大的成熟企业相比，面临不同的限制因素，这会影响它们的竞争动态和潜在的整合活动。

展望未来，关税政策与全球医疗设备贸易之间的相互作用将继续影响投资选择、战略伙伴关係以及可重复使用和一次性器械模式的相对吸引力。

主导细分市场的洞察，将设备类型、临床应用、终端用户环境、技术路径和配件生态系统转化为策略重点。

有效的商业策略始于对细分市场的精准理解。以器械类型为例，软性输尿管镜和半硬性系统之间存在差异。在软性输尿管镜领域，可进一步区分注重高解析度成像的数位软性平台和专注于传统光纤传输架构的光纤软性平台。这些器械层面的选择会影响手术范围、维修和再处理成本以及资金预算分配，因此每种器械都需要不同的临床依据和培训方法来推动其应用。

应用层级的细分区分了诊断和治疗两种应用情境。诊断应用着重于病灶检测和定位所需的检查和视觉化功能，而治疗应用则分为结石管理和肿瘤管理。结石管理流程进一步细分为取石篮策略和以体外震波碎石为中心的方案，每种方案都有其独特的配件相容性和操作人体工学要求。肿瘤管理流程依赖精确的切片检查能力和雷射消熔性能，这会影响设备的光学、偏转和能量传输要求。

最终用户环境对设备采用模式起着至关重要的作用。无论是独立运营还是隶属于医院的门诊手术中心，都优先考虑手术效率、简化的再处理流程以及可预测的单例手术运营成本；而无论是私立医院还是公立医院，在选择设备时则更注重资本摊销、手术种类丰富度以及服务水平预期。这些差异导致了不同医疗机构在商业性讯息、报销承诺和采用模式上的差异。

技术细分揭示了数位输尿管镜和光纤输尿管镜的平行发展。可重复使用型和抛弃式输尿管镜之间的策略选择取决于消毒基础设施、手术量和长期拥有成本的计算。最后，配件细分——例如雷射光纤与取石篮、钬光纤与铥光纤、标准取石篮与无尖端取石篮——决定了捆绑销售的机会和售后市场收入潜力。将产品蓝图与这些细分领域相匹配，有助于产生更有针对性的证据、制定量身提案的价值主张并实现差异化的商业性执行。

区域洞察分析着重阐述美洲、欧洲、中东和非洲以及亚太地区的市场采纳动态和结构性差异，并为打入市场策略提供启示。

地理位置对医疗器材的普及和商业性化进程有显着影响。在美洲，大型综合医疗系统、实力雄厚的私立医院以及活跃的门诊手术中心网络，共同推动了对高通量一次性抛弃式和功能丰富的可重复使用平台的需求。该地区的医保报销结构和资本规划週期，通常更倾向于已证实具有临床效率提升且单次手术成本可预测的医疗器械，从而影响着产品在医院和门诊环境中的价值评估。此外，该地区的诊疗路径优化计画和医院整合趋势也会影响采购量和标准化机会。

欧洲、中东和非洲地区不同的报销模式、监管时间表和医疗基础设施导致了不同的医疗设备应用模式。资源丰富的市场优先考虑先进的影像处理和用于预防感染的一次性设备，而新兴的医疗体系则优先考虑耐用、可维修且有本地服务网路支援的设备。这些市场的采购也会受到特定国家/地区的合约结构和当地经销商的影响，因此需要客製化的价格和服务提案。

亚太地区正经历着都市区三级医疗中心快速普及微创泌尿外科技术以及区域医院和门诊机构服务范围不断扩大的双重趋势。该地区对微创泌尿系统的投资以及不断提升的手术能力，为兼顾资本投入和单例经济效益的扩充性器械解决方案提供了支持。与本地製造商和经销商建立合作关係，以及开展旨在规范手术流程的培训项目，对于加速微创泌尿外科技术在亚太地区多样化医疗环境中的应用尤为有效。

了解这些区域差异，可以让製造商优先考虑证据产生、监管策略、当地采购行为、报销优先事项以及符合商业现实的商业模式。

公司层面的洞察重点在于产品组合差异化、製造地、智慧财产权趋势和伙伴关係模式。

输尿管镜设备领域的竞争格局取决于各公司如何建构产品系列，包括可重复使用和一次性光学元件、能量传输系统以及配套配件。领先的创新企业优先考虑整合解决方案，将高解析度视觉化、优化的雷射相容性和客製化的附件生态系统相结合，以创建连贯的临床工作流程。中型企业则通常强调针对特定目标的价值提案，例如经济实惠的一次性产品以及专用取物篮和光纤，以抢占特定手术领域的市场份额。

製造地和垂直整合能力会影响企业的竞争地位。拥有多元化生产和区域组装能力的企业更能抵御关税波动和供应链中断的影响，而依赖集中式生产的企业则面临不同的风险。与契约製造製造商合作、建立零件采购策略联盟以及与临床意见领袖共同开发契约，有助于在不损害企业财务状况的前提下拓展产品线。

智慧财产权和监管策略进一步凸显了企业的差异化优势。专有的影像软体、独特的偏转机制和光纤技术构筑了准入壁垒，并结合严格的临床检验，协助企业实现高端定位。同时，有效利用售后市场收入（例如配件、耗材和服务合约）的企业，能够增强经常性收入来源，并深化客户关係。

最后，市场进入策略也多种多样，从强调广泛临床培训和医院整合的直销模式，到优先考虑更广泛地域覆盖的分销商主导策略，不一而足。最成功的公司会根据上文讨论的终端用户细分和地理实际情况，量身定制其商业模式，投资于临床证据、教育项目和服务网络，以满足临床医生和采购团队的实际需求。

为行业领导者提供切实可行的建议，以加速采用、增强韧性并在临床和商业路径中获取价值

产业领导者应优先考虑模组化产品组合策略，以协调可重复使用设备和一次性设备并存。具体而言，产品设计应符合门诊手术中心和医院的运作实际情况，并专注于设定时间、消毒负担和配件相容性，这将有助于产品得到更广泛的应用。此外，开展有针对性的临床证据项目，证明产品能够提高手术效率并改善以患者为中心的治疗效果，对于与大型医疗机构和支付者进行有效沟通至关重要。

供应链韧性必须提升为策略重点。企业应扩大关键零件的多通路采购能力，在可行的情况下对区域组装合作伙伴进行资格认证，并对关税敏感型投入品实施库存缓衝。这些措施将有助于减轻贸易政策变化的影响，并确保向关键客户交货产品的可预测性。

在商业性，企业应采用差异化的合作模式，以反映终端用户细分。对于三级医院而言，注重实践培训、指导和结果追踪的高触感项目更为有效；而对于门诊手术中心而言，简化的采购方案和可预测的单例成本核算则更为适用。将内视镜、优化的雷射光纤和相容的配件打包在一起，可以简化采购决策，并建立可衡量的总医疗成本系统。

最后，投资数位化赋能和资料撷取，以量化流程层面的绩效，并支持与医疗服务提供者进行基于价值的对话。远端指导、远端设备健康远距离诊断和使用率分析报告能够创造更多收入和服务差异化的机会，同时增强临床信任和建立长期伙伴关係。

调查方法概述了数据三角测量、专家参与、检验通讯协定和分析框架，这些方法和框架用于得出本文提出的见解。

本研究采用多资讯研究途径，将对临床医生、采购负责人和行业高管的专家访谈与监管文件、临床文献和设备技术规范等辅助研究结合。主要资讯来源包括结构化访谈，旨在了解医院和门诊环境中的手术流程、设备偏好和采购标准。辅助分析则着重于设备设计特点、配件相容性和已发表的临床结果，以检验临床实践模式和技术性能声明。

本分析采用以细分为先的框架，以确保能够深入了解设备类型、临床用途、最终用户环境、技术配置和配件生态系统。交叉检验通讯协定将基于访谈的观察结果与产品文献和公开监管记录进行比较，以确认有关设备功能和预期用途的说法。敏感性检查透过对来自多个临床和商业性相关人员的意见进行加权，来解决单一来源证词可能造成的偏差。

我们对关税和供应链应对措施的影响进行了解读，结合了政策评估、供应商层面的资讯揭露以及采购负责人的观点，从而建构出切实可行的潜在策略应对方案。我们的区域分析包括对代表性市场的临床医生进行访谈，并审查报销和采购结构，以突出实际应用限制和驱动因素。这些调查方法提供了基于证据的综合分析，可为决策者制定商业规划和产品策略提供支援。

总结策略意义，并为希望根据执行摘要结果采取行动的相关人员概述优先的后续步骤

输尿管镜设备领域正处于曲折点，其特点是光学、能量传输和配件设计方面的进步，以及采购和医疗服务模式的转变。这些因素为那些能够将产品功能与医院和门诊手术中心的营运需求相结合，同时又能应对供应链韧性和不断变化的贸易政策风险的公司创造了明显的机会。最终能否被广泛接受，取决于能否证明其临床价值、简化手术流程，以及在各种医疗环境中实现可预测的营运经济效益。

相关人员的下一步优先步骤包括：明确细分市场的价值提案；加快针对性临床证据的收集，以满足终端用户的需求；以及增强生产和采购的灵活性，以应对关税和物流中断的影响。此外，各机构还需要优化其商业策略，以反映区域报销的实际情况，并针对不同类型的购买者（包括私人医院、商业性医院、独立门诊机构和医院附属门诊中心）调整通讯。

透过关注这些策略问题，企业及其医疗服务提供者合作伙伴可以成功应对不断变化的市场环境，抓住技术创新带来的机会，并改善接受诊断性和治疗性输尿管镜检查患者的治疗效果。报告的其余部分提供了详细的附录以及实用化这些结论所需的依证。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 增加一次性输尿管镜的使用，以降低污染风险
  • 将高清数位成像系统整合到柔性输尿管镜平台中
  • 开发用于提高手术精度的机器人输尿管镜平台
  • 雷射碎石术相容性的进步可加快输尿管结石的碎裂速度
  • 小型化可弯曲内视镜的出现，最大限度地降低了输尿管损伤的风险。
  • 人工智慧在即时石材检测和测绘领域的应用日益广泛
  • 符合人体工学的手把设计日益普及，旨在减少外科医生在长时间输尿管镜检查过程中的疲劳。
  • 重点关注永续材料和回收倡议，以实现环保输尿管镜製造。
  • 扩大一次性数位软性内视镜的使用范围，以缩短消毒週转时间
  • 泌尿系统设备製造商与人工智慧Start-Ups活性化，共同创新内视镜技术

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依设备类型分類的输尿管镜设备市场

  • 软性输尿管镜
    • 数位柔性
    • 光纤柔性
  • 半硬式输尿管镜

9. 按应用分類的输尿管镜设备市场

  • 诊断
    • 检查
    • 视觉化
  • 治疗
    • 石材管理
      • 篮框提取
      • 碎石
    • 肿瘤管理
      • 切片检查
      • 雷射消熔

第十章 以最终用户分類的输尿管镜设备市场

  • 门诊手术中心
    • 独立的
    • 附设医院
  • 医院
    • 私立医院
    • 公立医院

第十一章 依技术分類的输尿管镜设备市场

  • 数位输尿管镜
    • 可重复使用的
    • 一次使用
  • 纤维输尿管镜
    • 可重复使用的
    • 一次使用

第十二章 输尿管镜设备市场（依配件划分）

  • 雷射光纤
    • 钬雷射光纤
    • 铥雷射光纤
  • 石篮
    • 标准篮筐
    • 无倾倒篮

第十三章 输尿管镜设备市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 输尿管镜设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国输尿管镜设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Olympus Corporation
    • KARL STORZ SE & Co. KG
    • Boston Scientific Corporation
    • Cook Medical LLC
    • Stryker Corporation
    • Richard Wolf GmbH
    • Ambu A/S
    • Fujifilm Holdings Corporation
    • Teleflex Incorporated
    • Coloplast A/S
Product Code: MRR-4659C87137F4

The Ureteroscopy Devices Market is projected to grow by USD 3.80 billion at a CAGR of 7.32% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.15 billion
Estimated Year [2025] USD 2.31 billion
Forecast Year [2032] USD 3.80 billion
CAGR (%) 7.32%

A comprehensive introduction framing ureteroscopy device evolution across clinical demand, technology progress, procurement dynamics, and implications for strategic stakeholders

Ureteroscopy devices sit at the intersection of urology procedural innovation and minimally invasive care delivery, responding to simultaneous pressures from clinicians, healthcare systems, and patients for improved visualization, reduced procedural risk, and faster recovery. The clinical imperative to manage stone disease and urothelial lesions with precision has driven sustained interest in optics, energy delivery, and ancillary disposables that enhance stone extraction and tumor ablation workflows. Concurrently, evolving hospital and ambulatory surgical center priorities influence procurement cycles and device preference, while regulatory and reimbursement environments shape the speed of adoption.

Technological advances in digital imaging and single-use platforms have catalyzed reconsideration of capital and operating models across care settings. Digital flexible ureteroscopes have elevated image clarity and integration with ancillary imaging systems, while single-use offerings have emerged in response to sterilization complexity, cross-contamination concerns, and throughput constraints. At the same time, developments in laser technology and accessory design-such as baskets and fibers engineered for improved maneuverability and fragmentation efficiency-have narrowed the procedural trade-offs that clinicians weigh during device selection.

In this context, stakeholders must balance clinical efficacy, total procedural cost, and supply resilience. As care pathways decentralize and outpatient settings take on a larger share of urologic procedures, alignment between device design and operating environment becomes a critical determinant of commercial success. The remainder of this summary synthesizes the most consequential shifts, regulatory and trade impacts, segmentation-driven implications, regional nuances, and clear recommendations for leaders seeking to position their portfolios effectively.

Transformative Shifts Reshaping Clinical Practice, Technology Adoption, and Commercial Strategy in Ureteroscopy

The landscape for ureteroscopy devices is undergoing several convergent transformations that are altering clinical practice and commercial calculus. First, the maturation of high-resolution digital optics has changed clinician expectations for image quality and intraoperative decision making, enabling finer lesion characterization and more confident therapeutic maneuvers. This shift is reinforced by better integration with operating room visualization suites and image management systems, which together advance the role of ureteroscopy in complex diagnostic and therapeutic pathways.

Second, the rise of single-use technology is reshaping procurement models and infection control strategies. Facilities increasingly evaluate single-use options not solely on per-procedure cost but on throughput, reprocessing labor, and cross-infection risk mitigation. This has led to hybrid adoption patterns in which reusable and single-use systems coexist, with purchasing decisions driven by procedure volume, sterilization capacity, and clinical preference.

Third, energy delivery and accessory innovation, especially in laser fiber performance and basket design, are shifting the boundary of what can be achieved endoscopically. Improvements in lithotripsy efficiency and tumor ablation precision reduce the need for staged procedures and broaden the patient population eligible for minimally invasive management. These clinical gains translate into shifting procedural mixes across inpatient and ambulatory venues.

Finally, decentralized care delivery and growth in ambulatory surgical centers are prompting manufacturers to refine product portfolios for portability, simplified setup, and rapid turnover. Taken together, these shifts create both opportunity and complexity for product developers and health system partners, demanding coordinated investments in clinical training, evidence generation, and supply chain agility to realize potential gains.

Cumulative Impacts of United States Tariff Actions in 2025 on Supply Chain Structuring, Sourcing Decisions, and Cost Transparency

Recent tariff actions and trade policy signals announced for 2025 have increased the salience of supply chain configuration for companies operating in the ureteroscopy device space. Tariff adjustments applied to certain medical device inputs and finished goods have prompted manufacturers and distributors to reassess sourcing footprints, nearshoring options, and inventory strategies to preserve cost competitiveness and delivery reliability. In response, organizations are increasingly mapping supplier dependencies at the tier-two and tier-three levels to identify latent exposure to tariffed goods and to develop mitigation plans that span contract renegotiation, alternative sourcing, and selective vertical integration.

These policy shifts also influence pricing transparency and contractual negotiation dynamics with health systems and group purchasing organizations. Providers are demanding greater visibility into landed costs and contingency provisions, and procurement cycles now frequently incorporate clauses addressing import duties and supply interruptions. The cumulative effect has been a heightened emphasis on scenario planning and stress-testing commercial models under different trade policy trajectories.

On the manufacturing side, some firms are accelerating localized assembly or qualifying alternate contract manufacturers in non-tariff jurisdictions to reduce duty burden and shorten lead times. Others are redesigning component specifications to minimize the use of tariff-implicated items, while a subset is leveraging tariff mitigation mechanisms where available. Importantly, these responses are not uniform; small and mid-sized companies face different constraints compared with large established firms, which affects competitive dynamics and potential consolidation activity.

Going forward, the interplay between tariff policy and global medical device trade will continue to shape investment choices, strategic partnerships, and the relative attractiveness of reusable versus disposable device models, as duty-sensitive cost components flow through to procurement decisions and clinical adoption patterns.

Segmentation-driven insights translating device type, clinical application, end-user environment, technology pathways, and accessory ecosystems into strategic priorities

An effective commercial strategy begins with precise segment-level understanding. Device type considerations differentiate flexible ureteroscopes from semi-rigid systems; within flexible offerings, a further distinction exists between digital flexible platforms that prioritize high-definition visualization and fiber-optic flexible variants that emphasize traditional light-transmitting architectures. These device-level choices affect procedure scope, repair and reprocessing burdens, and capital budget allotments, and they require distinct clinical evidence and training approaches to drive adoption.

Application-level segmentation separates diagnostic use from therapeutic deployment. Diagnostic applications emphasize inspection and visualization capabilities necessary for lesion detection and mapping, while therapeutic use cases split between stone management and tumor management. Stone management workflows further bifurcate into basket extraction strategies and lithotripsy-centric approaches, each demanding specific accessory compatibility and procedural ergonomics. Tumor management workflows rely on precise biopsy capability and laser ablation performance, which in turn influence device optics, deflection, and energy delivery requirements.

End-user context plays a critical role in adoption patterns. Ambulatory surgical centers, whether freestanding or hospital-affiliated, prioritize throughput efficiency, simplified reprocessing, and predictable per-case operating expenses, whereas hospitals, whether private or public, weigh capital depreciation, breadth of procedural mix, and service-level expectations when selecting devices. These differences drive varied commercial messaging, reimbursement engagement, and deployment models across providers.

Technology segmentation highlights the parallel development of digital and fiber-optic ureteroscopes, each available in reusable and single-use configurations. Strategic choices between reusable and single-use variants hinge on sterilization infrastructure, procedural volume, and long-term cost-of-ownership calculus. Finally, accessory segmentation-such as distinctions between laser fibers and stone baskets and between holmium and thulium fibers or standard and tipless baskets-shapes bundled offering opportunities and aftermarket revenue potential. Aligning product roadmaps to these layered segments enables focused evidence generation, tailored value propositions, and differentiated commercial execution.

Regional insights highlighting adoption dynamics and structural differences across the Americas, Europe Middle East & Africa, and Asia-Pacific with implications for go-to-market strategies

Geographic context materially influences device adoption and commercial execution. In the Americas, large integrated health systems, a strong private hospital presence, and active ambulatory surgical center networks create demand for both high-throughput disposables and feature-rich reusable platforms. Reimbursement structures and capital planning cycles in this region often favor demonstrable clinical efficiency gains and predictable per-procedure costing, which shapes how products are evaluated across hospital and ambulatory settings. Additionally, pathway optimization initiatives and hospital consolidation trends in this region affect purchasing scale and standardization opportunities.

Within Europe, the Middle East & Africa, diversity in reimbursement models, regulatory timelines, and health infrastructure results in differentiated uptake patterns. High-resource markets place a premium on advanced imaging and single-use infection control benefits, while emerging healthcare systems emphasize durable, repairable devices supported by local service networks. Procurement in these markets may also be influenced by national contracting vehicles and regional distributors, necessitating tailored pricing and service propositions.

Asia-Pacific presents a mix of rapid adoption in urban tertiary centers and widening access in regional hospitals and ambulatory facilities. Investments in minimally invasive urology and expanding surgical capacity within the region favor scalable device solutions that balance capital expenditure with per-case economics. Partnerships with local manufacturers and distributors, along with training programs oriented toward procedure standardization, are particularly effective in accelerating adoption across diverse healthcare settings in Asia-Pacific.

Understanding these regional nuances allows manufacturers to prioritize evidence generation, regulatory strategy, and commercial models that align with local procurement behavior, reimbursement priorities, and operational realities.

Company-level insights focusing on portfolio differentiation, manufacturing footprint, intellectual property trends, and partnership models

Competitive dynamics in the ureteroscopy devices space are shaped by how firms configure product portfolios across reusable and disposable optics, energy delivery systems, and complementary accessories. Leading innovators prioritize integrated solutions that combine high-resolution visualization with optimized laser compatibility and bespoke accessory ecosystems to create sticky clinical workflows. Mid-market players frequently emphasize targeted value propositions-such as cost-effective single-use offerings or specialized baskets and fibers-to capture specific procedural niches.

Manufacturing footprint and vertical capability influence competitive positioning. Firms with diversified production and regional assembly capabilities can respond more flexibly to tariff shifts and supply disruptions, while those relying on concentrated manufacturing face different risk profiles. Partnerships with contract manufacturers, strategic alliances for component sourcing, and co-development agreements with clinical opinion leaders help expand product breadth without undermining balance sheets.

Intellectual property and regulatory strategy further differentiate companies. Proprietary imaging software, unique deflection mechanisms, and fiber technologies create barriers to entry and enable premium positioning when accompanied by rigorous clinical validation. At the same time, firms that effectively leverage aftermarket revenue through accessories, consumables, and service agreements strengthen recurring revenue streams and deepen customer relationships.

Finally, go-to-market approaches vary from direct sales models focused on high-touch clinical training and hospital integration to distributor-led strategies that prioritize broader geographic reach. The most successful organizations align their commercial model with the end-user segmentation and regional realities described earlier, investing in clinical evidence, education programs, and service networks that address the practical needs of clinicians and procurement teams.

Actionable recommendations for industry leaders to accelerate adoption, strengthen resilience, and capture value across clinical and commercial pathways

Industry leaders should prioritize modular portfolio strategies that reconcile the coexistence of reusable and single-use modalities. Specifically, aligning product design with the operational realities of ambulatory surgical centers and hospitals-focusing on setup time, sterilization burden, and accessory compatibility-will support wider adoption. In tandem, targeted clinical evidence programs that demonstrate procedural efficiency gains and patient-centered outcomes will be decisive in conversations with high-volume institutions and payers.

Supply chain resilience must be elevated to a strategic priority. Companies should expand multi-sourcing capabilities for critical components, qualify regional assembly partners where feasible, and implement inventory buffering for tariff-sensitive inputs. These actions reduce exposure to trade policy shifts and support predictable delivery performance for key customers.

Commercially, firms should adopt differentiated engagement models that reflect end-user segmentation. High-touch programs emphasizing hands-on training, proctoring, and outcomes tracking work well for tertiary hospitals, while streamlined procurement options and predictable per-case costing resonate with ambulatory surgical centers. Bundled offerings that package scopes, optimized laser fibers, and compatible baskets can simplify purchasing decisions and create measurable total cost of care narratives.

Finally, invest in digital enablement and data capture to quantify procedure-level performance and support value-based conversations with providers. Tele-mentoring, remote diagnostics for device health, and analytics reporting on utilization create additional revenue and service differentiation opportunities while reinforcing clinical trust and long-term partnerships.

Research methodology outlining data triangulation, expert engagement, validation protocols, and analytical frameworks used to derive the insights presented

This synthesis is grounded in a multi-source research approach that integrates primary expert interviews with clinicians, procurement leaders, and industry executives, combined with secondary examination of regulatory filings, clinical literature, and device technical specifications. The primary input included structured interviews designed to capture procedural workflows, device preferences, and procurement criteria across hospital and ambulatory settings. Secondary analysis focused on device design features, accessory compatibility, and published clinical outcomes to validate practice patterns and technology performance claims.

The analysis employed a segmentation-first framework to ensure that insights were relevant to device type, clinical application, end-user environment, technology configuration, and accessory ecosystems. Cross-validation protocols compared interview-based observations against product literature and public regulatory records to confirm claims regarding device capabilities and intended use cases. Sensitivity checks addressed potential bias from single-source testimony by weighting input across multiple clinical and commercial stakeholders.

Interpretation of tariff impacts and supply chain responses combined policy review with supplier-level disclosure and procurement leader perspectives to generate a practical view of likely strategic responses. The regional analysis drew on clinician interviews in representative markets and review of reimbursement and procurement structures to surface realistic adoption constraints and enablers. Together, these methodological elements produced an evidence-informed synthesis designed to support decision makers in commercial planning and product strategy.

Conclusion synthesizing strategic implications and outlining priority next steps for stakeholders seeking to act on the executive summary findings

The ureteroscopy device landscape is at an inflection point defined by converging advances in optics, energy delivery, and accessory design coupled with shifting procurement and care delivery models. These forces create distinct opportunities for firms that can align product functionality with the operational needs of hospitals and ambulatory surgical centers, while simultaneously addressing supply chain resilience and evolving trade policy risk. Adoption choices will hinge on the ability to demonstrate clinical value, simplify procedural workflows, and deliver predictable operating economics for diverse care settings.

Priority next steps for stakeholders include clarifying segment-specific value propositions, accelerating targeted clinical evidence that maps to end-user priorities, and strengthening manufacturing and sourcing flexibility to respond to tariff and logistics disruptions. Organizations should also refine commercial approaches to reflect regional reimbursement realities and to adapt messaging for distinct buyer types across private hospitals, public hospitals, freestanding ambulatory facilities, and hospital-affiliated outpatient centers.

By focusing on these strategic imperatives, companies and provider partners can better navigate the evolving landscape, capture opportunities presented by technological innovation, and deliver improved outcomes for patients undergoing diagnostic and therapeutic ureteroscopic procedures. The remainder of the report offers the detailed appendices and evidence base required to operationalize these conclusions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of single-use disposable ureteroscopes to reduce contamination risks
  • 5.2. Integration of high-definition digital imaging systems in flexible ureteroscope platforms
  • 5.3. Development of robot assisted ureteroscopy platforms for enhanced surgical precision
  • 5.4. Advancements in laser lithotripsy compatibility for faster ureteral stone fragmentation
  • 5.5. Emergence of miniaturized deflectable scopes to minimize ureteral trauma risks
  • 5.6. Rising implementation of artificial intelligence for real time stone detection and mapping
  • 5.7. Surge in ergonomic handle designs to reduce surgeon fatigue during prolonged ureteroscopy procedures
  • 5.8. Focus on sustainable materials and recycling initiatives for eco friendly ureteroscope production
  • 5.9. Expansion of single use digital flexible scopes to reduce sterilization turnaround times
  • 5.10. Rising collaborations between urology device manufacturers and AI startups for scope innovation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ureteroscopy Devices Market, by Device Type

  • 8.1. Flexible Ureteroscopes
    • 8.1.1. Digital Flexible
    • 8.1.2. Fiber-Optic Flexible
  • 8.2. Semi-Rigid Ureteroscopes

9. Ureteroscopy Devices Market, by Application

  • 9.1. Diagnostic
    • 9.1.1. Inspection
    • 9.1.2. Visualization
  • 9.2. Therapeutic
    • 9.2.1. Stone Management
      • 9.2.1.1. Basket Extraction
      • 9.2.1.2. Lithotripsy
    • 9.2.2. Tumor Management
      • 9.2.2.1. Biopsy
      • 9.2.2.2. Laser Ablation

10. Ureteroscopy Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Freestanding
    • 10.1.2. Hospital Affiliated
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals

11. Ureteroscopy Devices Market, by Technology

  • 11.1. Digital Ureteroscopes
    • 11.1.1. Reusable
    • 11.1.2. Single Use
  • 11.2. Fiber-Optic Ureteroscopes
    • 11.2.1. Reusable
    • 11.2.2. Single Use

12. Ureteroscopy Devices Market, by Accessories

  • 12.1. Laser Fibers
    • 12.1.1. Holmium Laser Fibers
    • 12.1.2. Thulium Laser Fibers
  • 12.2. Stone Baskets
    • 12.2.1. Standard Baskets
    • 12.2.2. Tipless Baskets

13. Ureteroscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ureteroscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ureteroscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Olympus Corporation
    • 16.3.2. KARL STORZ SE & Co. KG
    • 16.3.3. Boston Scientific Corporation
    • 16.3.4. Cook Medical LLC
    • 16.3.5. Stryker Corporation
    • 16.3.6. Richard Wolf GmbH
    • 16.3.7. Ambu A/S
    • 16.3.8. Fujifilm Holdings Corporation
    • 16.3.9. Teleflex Incorporated
    • 16.3.10. Coloplast A/S

LIST OF FIGURES

  • FIGURE 1. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. URETEROSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. URETEROSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. URETEROSCOPY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 304. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032